Upgrade to SI Premium - Free Trial

Ionis Pharmaceuticals (IONS) PT Raised to $106 at Barclays

March 25, 2026 3:58 PM
Barclays analyst Eliana Merle raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $106.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change